Back to trial detailsIntake questionnaire
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Applying to Rush MD Anderson Cancer Center · Chicago, Illinois
Answer a few short questions to share with the research team.
0 of 4 answered